Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors’ Liability Premiums
  • Florida’s KidCare

TRENDING TOPICS:

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors' Liability Premiums
  • Florida’s KidCare

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Aug 15 2016

Full Issue

Opioid Crisis: 'No One Wakes Up In The Morning And Says, I Want To Kill My Friend'

Prosecutors, in trying to think outside the box on how to make a dent in the opioid epidemic, are more frequently going after dealers in cases of a fatal overdose. Some say that's the wrong path to go down, though.

He knew he was in trouble even before he read the text message: "Did u hear what hapnd 2 ed?" Ed Martin III had been found dead in the bathroom of a convenience store. He'd mainlined fentanyl, an opioid up to 50 times more powerful than heroin. Michael Millette was sad that his friend, just 28, had died. But he was scared, too. He'd sold him his final fix. Millette fled to Vermont, but quickly returned [to New Hampshire] to sell more drugs to support his habit. Now, though, police had a tip that he'd been Martin's dealer. After he sold drugs to an informant, they arrested him. (Cohen, 8/13)

Faced with an alarming increase in opioid addiction, a growing number of prosecutors are charging dealers not just for selling but for the deaths of customers who overdose on heroin or fentanyl. Here are some questions and answers about opioid abuse and this approach to pursuing dealers. (Cohen, 8/13)

In other news on the opioid crisis —

Nearly 1,500 counties in the United States do not have a single physician licensed to prescribe buprenorphine, a medication widely considered one of the most effective treatments for people with opioid and heroin use disorders. To remedy this problem, the White House announced Friday (Aug. 12) it is offering free buprenorphine training for health care providers across the country and online. (Lipinski, 8/12)

This week, the DEA chose to keep pot on its list of most dangerous drugs, even though more and more states and cities are legalizing or decriminalizing pot use. But few Americans recognize a significant downside to the pot-legalization movement, which is addressed in an article in this month's Esquire magazine. (8/13)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ